22-21568615-G-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_003347.4(UBE2L3):c.27+844G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.185 in 152,066 control chromosomes in the GnomAD database, including 3,455 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.18 ( 3455 hom., cov: 31)
Consequence
UBE2L3
NM_003347.4 intron
NM_003347.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 1.40
Publications
84 publications found
Genes affected
UBE2L3 (HGNC:12488): (ubiquitin conjugating enzyme E2 L3) The modification of proteins with ubiquitin is an important cellular mechanism for targeting abnormal or short-lived proteins for degradation. Ubiquitination involves at least three classes of enzymes: ubiquitin-activating enzymes (E1s), ubiquitin-conjugating enzymes (E2s) and ubiquitin-protein ligases (E3s). This gene encodes a member of the E2 ubiquitin-conjugating enzyme family. This enzyme is demonstrated to participate in the ubiquitination of p53, c-Fos, and the NF-kB precursor p105 in vitro. Several alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Sep 2009]
UBE2L3 Gene-Disease associations (from GenCC):
- systemic lupus erythematosusInheritance: Unknown Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.395 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
UBE2L3 | NM_003347.4 | c.27+844G>T | intron_variant | Intron 1 of 3 | ENST00000342192.9 | NP_003338.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.185 AC: 28108AN: 151948Hom.: 3449 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
28108
AN:
151948
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.185 AC: 28107AN: 152066Hom.: 3455 Cov.: 31 AF XY: 0.196 AC XY: 14567AN XY: 74324 show subpopulations
GnomAD4 genome
AF:
AC:
28107
AN:
152066
Hom.:
Cov.:
31
AF XY:
AC XY:
14567
AN XY:
74324
show subpopulations
African (AFR)
AF:
AC:
2211
AN:
41546
American (AMR)
AF:
AC:
4651
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
AC:
808
AN:
3470
East Asian (EAS)
AF:
AC:
2108
AN:
5144
South Asian (SAS)
AF:
AC:
1338
AN:
4826
European-Finnish (FIN)
AF:
AC:
3386
AN:
10536
Middle Eastern (MID)
AF:
AC:
67
AN:
294
European-Non Finnish (NFE)
AF:
AC:
13010
AN:
67970
Other (OTH)
AF:
AC:
411
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1090
2180
3269
4359
5449
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
310
620
930
1240
1550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1134
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.